Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer

被引:48
|
作者
Wirtenberger, Michael
Frank, Bernd
Hemminki, Kari
Klaes, Ruediger
Schmutzler, Rita K.
Wappenschmidt, Barbara
Meindl, Alfons
Kiechle, Marion
Arnold, Norbert
Weber, Bernhard H. F.
Niederacher, Dieter
Bartram, Claus R.
Burwinkel, Barbara
机构
[1] German Canc Res Ctr, DKFZ, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany
[2] Karolinska Inst, Novum, Dept Biosci, Huddinge, Sweden
[3] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany
[4] Univ Hosp Cologne, CMMC, Dept Obstet & Gynaecol, Div Mol Gynecooncol, Cologne, Germany
[5] Tech Univ Munich, Klinikum Rechts Isar, Dept Obstet & Gynaecol, D-8000 Munich, Germany
[6] Univ Hosp Schleswig Holstein, Dept Obstet & Gynaecol, Div Oncol, Kiel, Germany
[7] Univ Regensburg, Inst Human Genet, D-8400 Regensburg, Germany
[8] Univ Dusseldorf, Ctr Clin, Dept Obstet & Gynaecol, Div Mol Genet, Dusseldorf, Germany
[9] Helmholtz Univ, Grp Mol Epidemiol, DKFZ, Heidelberg, Germany
关键词
D O I
10.1093/carcin/bgi374
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mutations of the human RecQ helicase genes WRN and BLM lead to rare autosomal recessive disorders, Werner and Bloom syndromes, which are associated with premature ageing and cancer predisposition. We tested the hypothesis whether three polymorphic, non-conservative amino acid exchanges in WRN and BLM act as low-penetrance familial breast cancer risk factors. Moreover, we examined the putative impact of p53 MspI 1798G > A, which is completely linked to p53PIN3, a 16 bp insertion/duplication that has been associated with reduced p53 expression, on familial breast cancer risk. Genotyping analyses, performed on 816 BRCA1/2 mutation-negative German familial breast cancer patients and 1012 German controls, revealed a significant association of the WRN Cys1367Arg polymorphism with familial breast cancer (OR = 1.28, 95% CI 1.06-1.54) and high-risk familial breast cancer (OR = 1.32, 95 % CI 1.06-1.65). The analysis of p53 MspI 1798G > A, which is completely linked to p53PIN3, showed a significantly increased familial breast cancer risk for carriers of the 16 bp insertion/duplication, following a recessive mode (OR = 2.15, 95% CI = 1.124.11). WRN Cys1367Arg, located in the C-terminus, the binding site of p53, is predicted to be damaging. The joint effect of WRN Cys1367Arg and p53 MspI resulted in an increased breast cancer risk compared to the single polymorphisms (OR = 3.39, 95% CI 1.19-9.71). In conclusion, our study indicates the importance of inherited variants in the WRN and p53 genes for familial breast cancer susceptibility.
引用
收藏
页码:1655 / 1660
页数:6
相关论文
共 50 条
  • [31] p53 in breast cancer: mutation and countermeasures
    Kumar, Sumit
    Walia, Vijay
    Ray, Maria
    Elble, Randolph C.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 4168 - 4178
  • [32] p53 polymorphisms and haplotypes in breast cancer
    Sjalander, A
    Birgander, R
    Hallmans, G
    Cajander, S
    Lenner, P
    Athlin, L
    Beckman, G
    Beckman, L
    CARCINOGENESIS, 1996, 17 (06) : 1313 - 1316
  • [33] p53 haplotype determination in breast cancer
    Weston, A
    Pan, CF
    Ksieski, HB
    Wallenstein, S
    Berkowitz, GS
    Tartter, PI
    Bleiweiss, IJ
    Brower, ST
    Senie, TR
    Wolff, MS
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1997, 6 (02) : 105 - 112
  • [34] Overexpression of p53 in human breast cancer
    Minguillon, C
    Heinze, T
    Schönborn, I
    Lichtenegger, W
    JOURNAL OF TUMOR MARKER ONCOLOGY, 1999, 14 (01): : 13 - 17
  • [35] P53 EXPRESSION IN BREAST-CANCER
    CATTORETTI, G
    RILKE, F
    ANDREOLA, S
    DAMATO, L
    DELIA, D
    INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) : 178 - 183
  • [36] P53 MUTATIONS IN BREAST-CANCER
    COLES, C
    CONDIE, A
    CHETTY, U
    STEEL, CM
    EVANS, HJ
    PROSSER, J
    CANCER RESEARCH, 1992, 52 (19) : 5291 - 5298
  • [37] Serum p53 antibody in breast cancer
    Yamamoto, Shinya
    Chishima, Takashi
    Adachi, Shouko
    Harada, Fumi
    Toda, Youko
    Arioka, Hitoshi
    Hasegawa, Naoki
    Kakuta, Yukio
    CANCER BIOMARKERS, 2014, 14 (04) : 203 - 206
  • [38] p53 polymorphism in ovarian and breast cancer
    Campbell, IG
    Eccles, DM
    Dunn, B
    Davis, M
    Leake, V
    LANCET, 1996, 347 (8998): : 393 - 394
  • [39] p53 as a mutagen test in breast cancer
    Hill, KA
    Sommer, SS
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2002, 39 (2-3) : 216 - 227
  • [40] FREQUENT P53 GENE-MUTATIONS AND NOVEL ALLELES IN FAMILIAL BREAST-CANCER
    GLEBOV, OK
    MCKENZIE, KE
    WHITE, CA
    SUKUMAR, S
    CANCER RESEARCH, 1994, 54 (14) : 3703 - 3709